Publications by authors named "Wafa Baqri"
Background And Purpose: Glioblastoma (GBM) is the most common malignant primary brain tumour in adults. Receipt of adjuvant therapies has been shown to exert a significant positive effect on patient survival. Little is known however about how changes in standards of care and healthcare system factors, such as access, affect real-world outcomes.
View Article and Find Full Text PDFBackground: Neuro-oncology care in Ontario, Canada has been historically centralized, at times requiring significant travel on the part of patients. Toward observing the goal of patient-centered care and reducing patient burden, 2 additional regional cancer centres (RCC) capable of neuro-oncology care delivery were introduced in 2016. This study evaluates the impact of increased regionalization of neuro-oncology services, from 11 to 13 oncology centers, on healthcare utilization and travel burden for glioblastoma (GBM) patients in Ontario.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to investigate the prevalence of long-delayed chemotherapy-induced nausea and vomiting (CINV) that occurs more than 120 hours after chemotherapy treatment, which has not been thoroughly researched before.
- It included data from 2048 patients who received either highly emetogenic or moderately emetogenic chemotherapy, revealing significant rates of long-delayed nausea and vomiting, especially in those who experienced symptoms on earlier treatment days.
- The findings indicated that long-delayed nausea could be as severe as nausea experienced in the delayed phase, highlighting the need for better management strategies for patients undergoing chemotherapy.